USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an antiāIL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
Education Center - SponsoredIntegrating Therapeutic Nutrition for Chronic Allergiesby • Hill's Pet NutritionIntended for veterinary audiences